{
  "id": 28339,
  "title": "Pricing for Oncology Biosimilars—Reply",
  "url": "https://urgent.news/2026/07/28/pricing-for-oncology-biosimilars-reply",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-28T00:00:00.000Z",
  "source": {
    "name": "JAMA",
    "slug": "jama",
    "url": "https://jamanetwork.com/journals/jama/fullarticle/2850798"
  },
  "original_language": "en",
  "account": null,
  "summary": "In Reply I thank Drs Jensen and Tichy for the opportunity to respond to the comments on our article on hospital adoption and pricing for oncology biosimilars. Their comments are factually correct and add insight into the complex process of drug payment and strengthen the core message of our article.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}